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ABSTRACT
Type II toxin–antitoxins systems are widespread in
prokaryotic genomes. Typically, they comprise two
proteins, a toxin, and an antitoxin, encoded by adja-
cent genes and forming a complex in which the enzy-
matic activity of the toxin is inhibited. Under stress
conditions, the antitoxin is degraded liberating the
active toxin. Though thousands of various toxin–
antitoxins pairs have been predicted bioinformati-
cally, only a handful has been thoroughly character-
ized. Here, we describe the AtaT2 toxin from a toxin–
antitoxin system from Escherichia coli O157:H7. We
show that AtaT2 is the first GNAT (Gcn5-related
N-acetyltransferase) toxin that specifically targets
charged glycyl tRNA. In vivo, the AtaT2 activity in-
duces ribosome stalling at all four glycyl codons
but does not evoke a stringent response. In vitro,
AtaT2 acetylates the aminoacyl moiety of isoaccept-
ing glycyl tRNAs, thus precluding their participation
in translation. Our study broadens the known tar-
get specificity of GNAT toxins beyond the earlier de-
scribed isoleucine and formyl methionine tRNAs, and
suggest that various GNAT toxins may have evolved
to specificaly target other if not all individual aminoa-
cyl tRNAs.
INTRODUCTION
Prokaryotic toxin–antitoxin (TA) modules encode a pro-
teinaceous toxin and a cognate antitoxin, which can be a
protein or an RNA (1). There is a substantial body of evi-
dence supporting the role of TA modules in plasmid main-
tenance (2) and abortive phage infection (3). While many
studies point towards the importance of TAs in the induc-
tion of persistence, virulence, or drug tolerance, the subject
remains controversial (4–7).
TAs are classified based on the nature of the antitoxin and
mechanism of toxin inactivation. The most diverse type,
type II, includes more than a hundred of experimentally ver-
ified modules. In addition, thousands of putative type II TA
modules have been found bioinformatically in sequenced
bacterial and archaeal genomes (8,9). Antitoxins of the type
II TA modules are proteins that bind their cognate tox-
ins and form inactive complexes (10). The mechanisms that
lead to toxin activation remain elusive and are subject of de-
bate (11). The majority of type II toxins are represented by
various RNases that act as translation inhibitors (12). A less
common class of type II toxins is comprised of proteins that
are characterized by the Gcn5-related N-acetyltransferase
(GNAT) fold (8,9). The GNAT class of toxins is mono-
phyletic and contains hundreds of predicted members found
in sequenced bacterial genomes (13). The mechanism of
action has been identified for five GNAT toxins (13–16).
Toxicity of several others was verified in vivo, but the tar-
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gets were not identified (17–21). All biochemically char-
acterized GNAT toxins acetylate the -amino group of a
specific aminoacyl-tRNA and therefore block protein syn-
thesis. The AtaT toxin from E. coli O157:H7 targets Met-
tRNAfMet (15), ItaT from E. coli HS specifically modifies
two Ile-tRNAsIle isoacceptors (13), while three TacT toxins
from Salmonella enterica Typhimurium exhibit a broader
specificity and target various tRNAs (16). Despite signifi-
cant insights about the activity of these toxins gained in in
vitro studies, little is known about the effects of GNAT-type
toxins on protein translation in the living cell.
The genome of E. coli O157:H7 str. Sakai contains
two GNAT class toxin–antitoxin modules, ataRT (locus
tags ECs4308–ECs4307) and ataRT2 (locus tags ECs4261–
ECs4262). While the AtaT toxin of the AtaRT module was
thoroughly characterized and shown to modify initiator
fMet-tRNAfMet exclusively (15), the functionality of the sec-
ond module, AtaRT2, was only demonstrated in in vivo tox-
icity tests (21). Phylogenetically, the toxins of AtaRT and
AtaRT2 modules are quite distant (29.2% sequence iden-
tity) (21) and could be expected to modify different tar-
gets inside the cell. In this study, we characterize AtaT2.
We show that this toxin specifically acetylates the aminoacyl
moiety of Gly-tRNAGly in vitro and stalls translating ribo-
somes at Gly codons in the living cell.
MATERIALS AND METHODS
Molecular cloning
Primers used for cloning are listed in Supplementary Table
S1.
To construct the plasmids for arabinose-inducible ex-
pression of ataT2 and ataRT2, the two genes were PCR-
amplified from E. coli O157:H7 str. Sakai genomic DNA
using AtaT2-F-EcoRI/AtaT2-R-HindIII and AtaR2-F-
EcoRI/AtaT2-R-HindIII primer pairs and Phusion DNA
polymerase (Thermo Scientific, USA). The PCR fragments
were cloned into pBAD33 between EcoRI and HindIII sites
resulting in pBAD-ataT2 and pBAD-ataRT2, respectively.
The pBAD-ataT2-Y139A was constructed by overlap-
extension PCR (22) using AtaT2-Y139F-F and AtaT2-
Y139F-R mutagenic primers pBAD-ataT2 as a template.
To create pET-str-AtaRT2-his plasmid, the ataRT2 module
was PCR-amplified using AtaR2-F-BamHI, and AtaT2-R-
XhoI primers, and the resulting PCR fragment was inserted
into pET22-strep-his vector (13) between BamHI and XhoI
sites. To construct plasmid overexpressing E. coli glycyl-
tRNA synthetase (GlyRS), the coding region of glyQ-glyS
was amplified using E. coli BW25113 genomic DNA as
a template and GlyRS-F-Bam/GlyRS-R-Xho primer pair.
The resulting PCR product was cloned into the pET22-str-
his vector linearized with BamHI and XhoI restriction en-
zymes, yielding pET22-str-GlyRS-his.
In vivo toxicity test
Escherichia coli BW25113 cells were transformed with
pBAD-ataT2, pBAD-ataRT2, and pBAD-ataT2-Y139A
vectors and plated on LB agar supplemented with 34 g/ml
chloramphenicol and 1% glucose. A single colony from
the freshly transformed plate was inoculated into 10 ml of
2× YT and allowed to grow to OD600 ∼ 0.3 at 37◦C. Cells
were divided into two cultures and grown at 37◦C for 30
min in the presence or absence of 1 mM arabinose. Serial
10-fold dilutions of the cultures were plated on LB agar sup-
plemented with 34 g/ml chloramphenicol and 1% glucose.
Metabolic labeling assays
Overnight culture of E. coli BW25113 carrying pBAD-
ataT2 plasmid or the empty vector pBAD33 were diluted
200-fold in MOPS medium lacking methionine (MOPS(-
Met) medium) supplemented with 33 g/ml chlorampheni-
col and 1% glucose, and allowed to grow at 37◦C to OD600
= 0.2. The cells were pelleted, resuspended in fresh MOPS(-
Met) medium supplemented with 33 g/ml chlorampheni-
col without glucose, and incubated for 30 min at 37 ◦C with
aeration. The culture was then induced with 1 mM arabi-
nose. The samples were collected before induction (0 min)
and at 5, 15, 30 and 60 min post-induction for radiolabel-
ing. A 28 l-aliquots of the cell cultures were combined with
2 l of MOPS(-Met) medium supplemented with 5 Ci of
[35S]-methionine. The mixture was incubated at 37◦C for 1
min and subsequently spotted onto 35 mm 3MM paper disc
(Whatman, USA). For the blank sample, 30 l of 5% TCA
was spotted on a paper disc. The paper discs were boiled for
5 min in 500 ml of 5% TCA. TCA was discarded, and boil-
ing was repeated in fresh 5% TCA. The discs were washed
with acetone, air-dried, and placed in scintillation vials filled
with 5 ml Ultima Gold scintillation cocktail (Perkin Elmer,
USA). Radioactivity was read using a scintillation counter
LS 6000 (Beckman Coulter, USA). Background radioac-
tivity was subtracted, and the data were normalized to the
empty vector control before the induction (at 0 min).
Overnight cultures of the wild-type E. coli BW25113
transformed with pBAD33-ataT2 or control vector
pBAD33, and the mutant E. coli strain BW25113 ΔrelA
harboring pBAD33 were diluted to OD600 = 0.1 in
MOPS medium containing 0.4% glycerol and 33 g/ml
chloramphenicol and grown at 37◦C for 1 h. 50 l of [32P]-
orthophosphoric acid (1 mCi/ml, 8500 Ci/mmole, Perkin
Elmer, USA) was added to 1 ml of each culture (50 Ci/ml
final radioactivity) followed by incubation at 37◦C for 40
min. The cultures were induced with 1 mM of arabinose, or
serine hydroxamate and incubation continued for 10 min
at 37◦C. The metabolically radiolabeled nucleotides were
extracted and subjected to thin-layer chromatography as
described (23), followed by autoradiography.
Protein expression and purification
An overnight culture of E. coli BL21(DE3) cells car-
rying pET-str-ataRT2-his plasmid was diluted 1:200 in
2× YT medium supplemented with 100 g/ml ampicillin
and grown at 37◦C with aeration to OD600 = 0.8. Pro-
tein expression was induced with 1 mM isopropyl -D-1-
thiogalactopyranoside (IPTG). After induction, the culture
was maintained at 18◦C for 16 h. The cells were pelleted by
centrifugation and washed with buffer W (20 mM Tris–HCl
pH 8.0, 150 mM NaCl, 1% -mercaptoethanol).
For purification of the active AtaT2 toxin, the cells were
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150 mM NaCl, 5 M guanidinium hydrochloride, 1% -
mercaptoethanol) and lysed by sonication. The lysate was
then clarified by centrifugation and combined with TALON
CellThru Co2+-chelating resin (Takara-Clontech). Upon in-
cubation with gentle mixing at 4◦C for 4 h, the resin was
washed with buffer W. AtaT2 was eluted with elution buffer
under denaturing conditions (500 mM imidazole, 20 mM
Tris–HCl pH 8.0, 150 mM NaCl, 5 M guanidinium hy-
drochloride, 1% -mercaptoethanol). Eluted AtaT2 was re-
folded by dialysis at 4◦C for 16 h in 2 l of dialysis buffer (20
mM Tris–HCl pH 8.0, 20 mM NaCl, 5% glycerol, 1 mM
DTT). The fraction of AtaT2, which remained soluble af-
ter dialysis, was concentrated, flash-frozen in liquid nitro-
gen, and stored at −80◦C.
For tandem affinity purification, the harvested cells were
resuspended in buffer W supplemented with 0.1 mM PMSF
and lysed by sonication. The lysate was clarified by centrifu-
gation and incubated with TALON Co2+-chelating agarose
(Takara-Clontech) with agitation at 1◦C for 2 h. The resin
was washed with buffer W, and the AtaR2-AtaT2 complex
was eluted with imidazole elution buffer (500 mM imida-
zole in buffer W). The eluted fraction was mixed with Strep-
Tactin Superflow Plus agarose (Qiagen, USA) and incu-
bated with agitation at 4◦C for 2 h. The resin was washed
with buffer W and eluted with desthiobiotin elution buffer
(2.5 mM desthiobiotin, in buffer W). Protein fractions were
analyzed by Laemmli 12% polyacrylamide gel electrophore-
sis (SDS-PAGE).
Size-exclusion chromatography of the AtaRT2 complex
was performed on a Superdex 200-5/150 GL column (GE
Healthcare, USA). A 25 l-aliquot of the protein frac-
tion eluted from Strep-Tactin resin was applied on the col-
umn pre-equilibrated with 10 mM Tris–HCl pH 8.0, 150
mM NaCl buffer. To calculate the molecular weight of
the AtaR2–AtaT2 complex, the Gel Filtration LMW and
HMW Calibration kits (GE Healthcare, USA) were used.
Proteins were eluted at 0.2 ml/min flow rate. Protein frac-
tions were analyzed by 12% SDS-PAGE.
Escherichia coli BL21(DE3) cells transformed with pET-
str-GlyRS-his and E. coli JW1195 strain from ASKA col-
lection (24) were used for purification of GlyRS and Pth,
respectively, as described earlier (13).
In vitro translation and toeprinting assays
The DNA template for in vitro transcription-translation of
ataR2 was prepared by PCR using the pBAD-ataRT2 vec-
tor template and T7-ataR2-F and T7-ataR2-R primers. The
in vitro coupled transcription–translation reactions were
carried out by PURExpress kit (NEB, USA) using DNA
templates encoding ataR2 or the dihydrofolate reductase
(DHFR) (NEB, USA). The in vitro translation of firefly lu-
ciferase was carried our with in vitro transcribed mRNA
(Luciferase T7 Control DNA Promega, USA). Before tem-
plate addition, translation reactions were incubated for 10
min at 37◦C in the presence of 0.2 mM of acetyl coenzyme
A, with and without 2 M AtaT2. DHFR- and ataR2-
translation reaction mixtures were supplemented with Flu-
oroTect™ GreenLys in vitro Translation Labeling System
(Promega, USA). The fluorescent products of in vitro trans-
lation reactions were analyzed by 12% SDS-PAGE, and vi-
sualized by Typhoon fluorescence gel imager (GE, USA).
The enzymatic activity of in vitro synthesized luciferase
was measured by detection of chemiluminescence in the
presence of 0.1 mM D-luciferin with VictorX5 multireader
(Perkin-Elmer, USA).
The toeprinting assay was carried out using Rst1 and
Rst2 mRNA as templates as described in (25), except that
reactions were preincubated for 10 min with 0.4 mM Ac-
CoA with or without the addition of 2 M AtaT2.
In vitro tRNA modification and RNaseT1 treatment
The tRNA aminoacylation was performed in 20 l of re-
action buffer (9 mM Mg-acetate, 5 mM KH2PO4 (pH 7.3),
95 mM K-glutamate, 5 mM NH4Cl, 0.5 mM CaCl2, 1 mM
spermidine, 8 mM putrescine, 1 mM DTT) supplemented
with 5 mM ATP, 0.5 mM of glycine, 1 M glycyl-tRNA
synthetase and 3 g of the glyV tRNA (Subriden RNA,
Rollingbay, WA, USA). The reaction mixture was incubated
at 37◦C for 30 min, quenched with 20 mM EDTA, and then
supplemented with 0.4 mM AcCoA and 2 M AtaT fol-
lowed by incubation at 37◦C for 10 min. Finally, the re-
action was mixed with 1 M of Pth and incubated at 37◦
C for additional 10 min. At each step, a 3 l-aliquot was
collected and treated with 1U of RNase T1 (NEB, USA)
for 10 min and analyzed by mass-spectrometry using Ul-
trafleXetreme MALDI-TOF/TOF (Bruker Daltonik, Ger-
many) equipped with Nd laser. The MH+ molecular ions
of RNase T1-treated tRNA were measured in linear mode;
the accuracy of average mass peak measurement was within
1 Da.
Preparation of the ribosome footprint fragment library
Escherichia coli BW25113 cells transformed with pBAD33-
ataT2 or empty pBAD vector were grown overnight in 10 ml
of LB medium supplemented with 34 g/ml chlorampheni-
col and 1% glucose. The overnight cultures were diluted
200-fold into 200 ml of MOPS medium supplemented with
33 g/ml chloramphenicol and 1% glucose and were grown
at 37◦C with vigorous shaking to an OD600 of 0.2. The cells
were pelleted and resuspended in fresh MOPS medium sup-
plemented with 33 g/ml chloramphenicol without glucose
and grown at 37◦C for 30 min, followed by 15 min induc-
tion with 1 mM arabinose. The cell cultures were diluted
with MOPS medium to OD600 = 0.6, cells were harvested
by rapid filtration, flash-frozen in liquid nitrogen and cryo-
lyzed in 650 l of lysis buffer (20 mM Tris–HCl pH 8.0, 10
mM MgCl2, 100 mM NH4Cl, 5 mM CaCl2, 0.4% Triton X-
100, 0.1% NP-40) containing 65 U of RNase-free DNase I
(Roche), 208 U of SUPERase•In™ RNase inhibitor (Invit-
rogen), and 3 M GMPPNP (Sigma-Aldrich), as described
in (26). The cellular lysates were clarified by centrifugation
at 20 000 × g at 4◦C for 10 min. The lysates were diluted
with the lysis buffer to adjust the OD260 to 0.1 in the fi-
nal volume of 220 l and treated with ∼450 U of MNase
(Roche) at 25◦C for 1 h. The reaction was quenched by the
addition of EGTA to the final concertation of 5 mM. The
monosomal material was purified by sucrose gradient cen-
trifugation. RNA purification and double-stranded DNA
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Data analysis
The Ribo-seq data were analyzed using the pipeline de-
scribed by Mohammad et al. (27) (available at github.com/
greenlabjhmi/2018 Bacterial Pipeline riboseq) and custom
python/R scripts. The raw reads were trimmed and quality
filtered with Skewer 0.2.2 (28). Reads shorter than 15 nt and
longer than 40 nt were excluded. We first aligned reads to
tRNA or rRNA sequences to filter them out. The remain-
ing reads were uniquely mapped to the MG1655 genome
(NC 000913.2). All mapping steps were performed using
Bowtie 1.2.2, allowing no more than two mismatches (29).
Ribosome density was calculated as the number of 3′-ends
of footprints normalized by the total number of uniquely
mapped reads (in millions). ORFs shorter than 170 nt and
those with the average ribosome density per codon less than
1 (0.33 per nt) were excluded from further analysis. The first
50 nt from the start codon and the last 20 nt before the stop
codon of each ORF were also excluded from the analysis
(27).
To analyze ribosome distribution over the ORFs lengths,
we binned each ORF into 10 segments, and for each seg-
ment, obtained percentages of ribosome density along the
ORF. 1891 ORFs satisfying the previously mentioned cri-
teria in both toxin and control samples were selected for
this analysis. Since the data represent fractions, we treated
them as compositions. Thus, the statistical inference was
performed after the isometric log-ratio (ilr) transformation.
The vectors were compared using paired Hotelling’s T2 test
(P-value < 0.01). Normality was tested using acompNor-
malGOF function of the ‘compositions’ R package. For
graphical representation, geometric means were used since
it is a standard measure of central tendency for composi-
tional data.
The pause score for each nt position was calculated by
dividing the ribosome density by the average density on the
gene. The positions of the A site of ribosomes were assigned
using 11 nt shift from the 3′ ends of footprints. To accurately
determine the shift value, we analyzed the average ribosome
density for all ORFs aligned at either the start or the stop
codons (Supplementary Figure S1). Pause scores for codons
in the A site were calculated by averaging the pause score
values for all three nucleotides.
RESULTS
To test whether the toxicity of AtaT2 depends on its acetyl-
transferase activity, we expressed the wild-type AtaT2 alone
or together with its cognate antitoxin AtaR2, and the
catalytically-inactive AtaT2 mutant using E. coli BW25113
cells which lack an AtaRT2 module of their own. Genes of
the AtaT2 module were introduced on a pBAD plasmid un-
der the control of an arabinose-inducible promoter. In the
AtaT2 mutant, the conserved tyrosine Y139, which serves
as the general acid during acetyl group transfer of other
characterized GNAT toxins (30), was replaced with alanine.
While even a transient, 30-minute, expression of wild-type
ataT2 dramatically decreased the number of viable cells in
the population, expression of the AtaT2-Y139A mutant, or
the toxin–antitoxin pair (AtaRT2) had no impact on cell vi-
ability (Figure 1A).
To test whether the two components of the AtaRT2 mod-
ule form a complex, we tagged the AtaT2 toxin with a strep-
tag, and the AtaR2 antitoxin with a hexahistidine tag and
the dual construct was expressed in E. coli cells. After sub-
jecting the induced cells’ lysate to tandem affinity chro-
matography, both AtaT2 and AtaR2 were recovered in the
eluate (Supplementary Figure S2A). Analysis of the eluted
material by size exclusion chromatography revealed a single
peak with an apparent molecular weight of 99 kDa (Supple-
mentary Figure S2B), which corresponds to a heterohexam-
eric complex of AtaT2–AtaR2 where toxin dimer is bound
to antitoxin tetramer. The same stoichiometry was observed
previously for the GNAT-type TA complexes AtaRT and
KacAT (31,32). Overall, these data show that the ataRT2 lo-
cus indeed encodes a bona fide type II toxin–antitoxin mod-
ule of the GNAT toxin group.
All GNAT-type toxins studied to date are translational
inhibitors, which act by modifying aminoacylated tRNAs
(14,15). To test if AtaT2 also inhibits protein synthesis, we
purified AtaT2 (see Materials and Methods) and analyzed
its functional activity in an in vitro translation system using
the firefly luciferase reporter assay. As shown in Figure 1B,
the addition of either AtaT2 or acetyl-CoA, a donor of the
acetyl group used by GNAT enzymes, alone did not affect
the luciferase synthesis. In contrast, when the reaction was
supplemented with both AtaT2 and acetyl-CoA, the pro-
duction of luciferase was abolished (Figure 1B). Thus, sim-
ilar to the other GNAT-type toxins, AtaT2 readily inhibits
protein synthesis and such inhibition likely requires acety-
lation of a specific target.
The mechanisms of cellular toxicity of all type II GNAT
toxins have been inferred so far only from the in vitro assays.
While this approach is informative, it may not adequately
reflect the effect of the toxin on protein synthesis in the liv-
ing cell. To determine how AtaT2 influences translation in
vivo, we used ribosomal profiling (Ribo-seq), a technique
that reveals the distribution of ribosomes on cellular mR-
NAs with subcodon resolution (33). Previous studies have
amply demonstrated the utility of Ribo-seq for elucidat-
ing the mechanisms of action of several protein synthesis
inhibitors (34–37), including type II toxins (38,39). E. coli
BW25113 cells were transformed with pBAD-ataT2 plas-
mid or an empty pBAD vector. Exponentially growing cells
were induced with arabinose for 15 min, a time sufficient to
achieve a near-complete inhibition of protein synthesis by
AtaT2 (Supplementary Figure S3), then collected by rapid
filtration and processed following established Ribo-seq pro-
tocols (26,27). The ribosomal footprints were mapped to the
genome, and the distribution of ribosomes was compared
between toxin-induced and control samples. For the analy-
sis, we selected genes longer than 170 nt and with an aver-
age ribosome density higher than 1 per codon. We first an-
alyzed how the ribosome density changes across the length
of ORFs. To this end, we partitioned each ORF into 10 seg-
ments of equal length (excluding 50 and 20 nucleotides from
the 5′- and 3′-end, respectively), and for every segment, cal-
culated percentages of the total number of footprints lo-
cated within the segment. In the control sample, the ribo-
somes were distributed relatively evenly across the entire
protein-coding region. In contrast, expression of ataT2 led
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Figure 1. AtaT2 inhibits protein synthesis in an acetyl-CoA-dependent manner. (A) Substitution of a conservative acetyl-CoA-binding Y139 abolishes the
toxicity of AtaT2 GNAT protein. Serial dilutions of the E. coli BW25113 cell harboring pBAD plasmid encoding wild-type or mutant AtaT2 toxin grown
for 60 min in the presence or absence of the inducer. Cells expressing ataRT2 operon were used as a control. (B) The activity of firefly luciferase (expressed
in relative luminescene units, RLU) synthesized in a coupled in vitro transcription-translation system in the absence or presence of AtaT2, acetyl-CoA or
both. The time-course of each reaction is shown as colored trace (see legend above the plot).
3′-end of the coding regions. Only ∼1/3 of the ribosomes
that successfully initiated translation were able to reach the
end of an ORF in cells synthesizing the toxin (Figure 2A).
This result indicates that AtaT2 action leads to inefficient
elongation of translation. A similar drop in ribosome den-
sity along the ORF length was observed for RNase-type
toxins, known to inhibit protein synthesis (38,39).
To investigate whether AtaT2 induces specific changes in
distribution of ribosomes across mRNAs, we examined rel-
ative ribosome occupancy (pause score) in the 100 ORFs
whose mRNAs had the highest average ribosomal density.
A comparison between AtaT2 and control samples revealed
significant redislocation of ribosomes (exemplified in Fig-
ure 2B and Supplementary Figure S4). To analyze systemat-
ically the nature of toxin-induced ribosome pausing across
the genome, we calculated the mean pause score values for
all amino acids in the ribosomal A-site (Figure 2C). In the
control sample, a notably higher than average pause score
was observed for ribosomes containing Ser codons in the
A site (Figure 2S). This type of pausing at ‘hungry’ Ser
codons has been previously reported for Ribo-seq experi-
ments in bacteria and most probably is caused by the deple-
tion of charged tRNASer cells during cell collection (27,40).
In the ataT2-expressing cells, ribosomes specifically pause
at Gly codons (Figure 2C), thus indicating that transla-
tion is arrested when glycine needs to be incorporated in
the growing protein chain. No prominent increase in pause
score at Ser codons was observed in the AtaT2 sample,
probably reflecting the inability of ribosomes to reach the
‘hungry’ Ser codons due to pausing at upstream Gly codons.
The observed ribosomal arrest at a specific codon in the
A-site suggests that the cognate tRNA is either uncharged,
degraded, or otherwise corrupted and thus can not be used
in the translation. Because the accumulation of uncharged
tRNA in the cell induces the synthesis of ppGpp (41), we
tested whether this alarmone accumulates after induction
of ataT2 expression for 10 min. As expected, we observed
ppGpp accumulation in control cells treated with serine hy-
droxamate, an inhibitor of Ser-tRNA synthetase (Figure
2D). In contrast, ppGpp remained undetectable in cells ex-
pressig AtaT2, indicating that the toxin action does not
increase the concentration of uncharged tRNA. As direct
binding of RelA to uncharged tRNA is required for activa-
tion of ppGpp synthesis (42,43), we reasoned that the most
likely cause of ribosome pausing at Gly codons observed in
our Ribo-seq data is the inability of Gly-tRNAGly to partic-
ipate in translation due to specific modification by AtaT2.
Three isoaccepting tRNAsGly with overlapping specificity
are encoded in the E. coli genome (44). tRNA(CCC) recog-
nizes the GGG codon, tRNA(UCC) decodes the GGG and
GGA codons, while the most abundant tRNA(GCC) is re-
sponsible for the recognition of codons GGC and GGU.
The pause scores for all glycine codons in the AtaT2 sam-
ple were comparable, with slightly stronger pausing at the
GGA codon, thus suggesting that AtaT2 can corrupt all
aminoacylated Gly isoacceptor tRNAs with some bias to-
ward tRNA(UCC) (Figure 2E).
We verified the results of Ribo-seq analysis in a cell-free
translation system by primer extension inhibition (toeprint-
ing) analysis (45,46). Two synthetic mRNAs encoding dif-
ferent protein products, each containing all 20 amino acids
(25), were translated in the presence of acetyl-CoA with or
without AtaT2, and the sites of ribosome arrest were de-
tected. In the presence of the toxin, translating ribosomes
became arrested specifically at the Gly codon of either one
of the two templates (Figure 3), consistent with the scenario
that AtaT2-modified Gly-tRNAGly is incapable of partici-
pating in translation.
Previously studied GNAT toxins were shown to acety-
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Figure 2. AtaT2 induces ribosomal stalling at Gly codons in the living cell. (A) Distribution of ribosome density across coding regions in cells harboring
pBAD33-ataT2 (red) or empty pBAD vector (grey). Each coding region was divided into ten equal segments from 5′ to 3′-end. For every segment percent-
ages of total ribosome density was calculated. The plot represents geometric means. The difference was evaluated with paired Hotelling’s T2 test (P-value
< 0.01). (B) Ribosomal pause score profiles over the sodA gene observed in cells expressing AtaT2 (red) and in control (dark grey). Grey vertical lines
indicate positions of Gly codons. The pause score values were calculated as ribosome density at each nucleotide of the sodA gene divided by the average
ribosome density on the gene. (C) Average pause scores for specific codons located in the ribosomal A-site. (D) AtaT2 expression does not induce ppGpp
synthesis. Thin-layer chromatogram of extracts of cells grown in MOPS rich medium supplemented with [32P]-orthophosphoric acid and arabinose. Lane
1, E. coli BW25113 relA/pBAD33; lane 2, E. coli BW25113/pBAD33; lane 3, E. coli BW25113/pBAD33 in the presence of 1 mM of serine hydroxamate;
lane 4, E. coli BW25113/pBAD33 ataT2. (E) Average pause score for individual Gly codons located in the ribosomal A-site.
To determine how exactly AtaT2 alters Gly-tRNA, we
purified native glyV tRNAGly and analyzed the prod-
ucts of its in vitro modification by the purified AtaT2
using mass spectrometry. T1 nuclease treatment of un-
charged glyV tRNA released an RNA fragment with
m/z 3760, corresponding to 3′-terminal oligonucleotide
5′-UpUpUpCpCpCpGpCpTpCpCpA-3′ (Figure 4, top
panel). The in vitro aminoacylation of glyV tRNAGly by
purified glycyl-tRNA synthetase (GlyRS) increased the
m/z value of this fragment by 57 Da, corresponding to
the addition of glycyl moiety (Figure 4, second panel
from the top). When aminoacylated glyV tRNAGly was
treated with AtaT2 in the presence of acetyl-CoA, the
MH+ ions corresponding to this fragment increased fur-
ther by 42 Da, matching the addition of an acetyl group.
AtaT2 did not modify the control Ile-tRNAIle (Supplemen-
tary Figure S5). N-acetylated aminoacyl-tRNA resembles
peptidyl-tRNA and can serve as a substrate for peptidyl-
tRNA hydrolase (Pth). The addition of Pth to AtaT2-
modified Gly-tRNA resulted in the accumulation of a
fragment, corresponding to uncharged tRNAGly (Figure
4, bottom panel), confirming that AtaT2 modifies Gly-
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Figure 3. In vitro analysis of AtaT2-induced ribosome stalling. Synthetic Rst1 (left panel) and Rst2 (right panel) templates encoding oligopeptides contain-
ing all amino acids (25) were translated in vitro in the absence (1) or presence (2) of AtaT2 toxin followed by reverse transcription. Samples were separated
by sequencing polyacrylamide gel electrophoresis alongside with a sequence ladder and visualized by autoradiography. Specific bands seen in the AtaT2
samples correspond to abortive reverse transcripts accumulated due to the collision of the stalled ribosome and reverse transcriptase. The first nucleotide
of the A site-codon is located 13 nt upstream of the position of reverse transcriptase stalling (45). The sequence of peptides encoded in Rst1 and Rst2
templates are shown to the left of the corresponding autoradiogram. The positions of the first nucleotide of the start and stop codons are indicated with
black arrows; the position of the first nucleotide of the codon located in the A site of the stalled ribosome is indicated with a red arrow.
DISCUSSION
In this work, we characterized the mechanism of toxicity of
E. coli O157:H7 AtaT2, a member of extensive but insuf-
ficiently studied family of GNAT toxins. Since AtaT2 has
only distant similarity to other GNAT toxins with known
specificity, we reasoned that it might have a different target
and/or mode of action. Because the in vitro approach for
toxin target identification alone may lead to erroneous con-
clusions (38), we combined in vivo and in vitro approaches
to identify the AtaT2 target. We showed that in vivo and in
vitro, AtaT2 acts as a potent inhibitor by arresting transla-
tion, specifically at Gly codons. We further established that
AtaT2 acetylates the -amino group of the glycyl moiety of
Gly-tRNAGly, making it unable to participate in the trans-
lation process.
The extended dwelling time at glycine codons results in an
overall decrease in the number of ribosomes that are able to
complete translation (Figure 2B). Because in the Ribo-seq
data, the ribosome density was not confined exclusively to
Gly codons, the ribosomes apparently can translate through
them in the presence of AtaT2 though with reduced effi-
ciency. Therefore, a fraction of Gly-tRNAGly in the cell re-
mains unmodified by the toxin at our conditions. Several
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Figure 4. AtaT2 acetylates glycyl residue attached to tRNAGly. Left pan-
els, MALDI-TOF-MS spectra of the products of the reactions depicted
schematically on the right. tRNAGly was sequentially treated with gly-
cyl tRNA synthetase (GlyRS), AtaT2, and Pth enzyme. At each step, an
aliquot was treated with T1 RNase and analyzed by MALDI-TOF-MS.
The MH+ ions at m/z 3670, m/z 3727 and m/z 3769 correspond to the 3′-
terminal fragments of glyV tRNA, glycylated glyV tRNA and glyV tRNA
carrying acetylated glycyl moiety, respectively.
toxin could be insufficient to modify all Gly-tRNAs; ii) a
salvage pathway, e.g. hydrolysis of acetyl-Gly-tRNA by Pth
(Figure 4), could regenerate intact tRNAsGly, making them
available for new rounds of aminoacylation; and iii) misin-
corporation of a near-cognate aminoacyl-tRNA at hungry
glycine codons or frameshifting could allow the ribosome
to continue translation past the pause site.
The expression of type II TAs is negatively regulated
by cognate toxin–antitoxin complexes (10). Strikingly, the
AtaR2 antitoxin sequence does not contain any glycyl
residues. As an expected consequence, the in vitro transla-
tion of AtaR2 is not inhibited in the presence of AtaT2
(Supplementary Figure S6). We speculate that continued
synthesis of the antitoxin in the presence of the toxin may
help to maintain a negative feedback loop that prevents the
excess synthesis of AtaT2 and facilitates the recovery of cells
from the toxin action.
The TA systems are ubiquitously present on plasmids and
in bacterial and phage genomes (8,9). Stable maintenance
of a particular TA may be indicative of its potential benefi-
cial role to the host or result from a selfish, addictive behav-
ior of its products. The role of chromosomally-encoded TA
modules, including AtaRT2 described here, remains unclear
as recent studies have questioned the previously postulated
functions of TAs (6). It was proposed that chromosoma-
lly encoded AtaRT and AtaRT2 evolved as anti-addiction
modules as antitoxin AtaR can counteract the toxic action
of plasmid-borne AtaTpl (21). Yet, the simultaneous main-
tenance of an antitoxin and the potentially harmful toxin in
the genome solely to counteract plasmid addiction modules
seems redundant, suggesting that there may be alternative
roles for chromosome-encoded TA modules. The fact that
three GNAT toxins with an established mechanism of ac-
tion, AtaT, ItaT, and AtaT2, recognize distinct sets of tR-
NAs, i.e. formyl methionine (15), isoleucine (13) and glycine
(this work), respectively, suggests that among hundreds of
yet uncharacterized toxins there could be those that specif-
ically target other if not all individual aminoacyl tRNA. It
is tempting to speculate that chromosome-encoded GNAT
toxins targeting different aminoacyl tRNAs serve as global
regulators responsible for fine-tuning of translation effi-
ciency under stress conditions.
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